BACKGROUND Fluorine-18-sodium fluoride ( 18 F-NaF) uptake is a marker of active vascular calcification associated with high-risk atherosclerotic plaque.
A bdominal aortic aneurysm (AAA) disease affects up to 5% of men aged 64 to 75 years, and its prevalence is increasing in more elderly populations (1) . With progressive AAA expansion over time, there is an increasing risk for often fatal rupture, representing the 12th commonest cause of death among older men (2) . Consequently, patients with AAA enter an ultrasound-based surveillance program, with the aim of facilitating preemptive elective aneurysm repair to avoid fatal rupture. AAA surveillance relies on serial measurements of aneurysm diameter, which is currently the best clinical predictor of further expansion and rupture (3, 4) . However, AAA growth is nonlinear, unpredictable, and influenced by biomechanical processes that cannot be predicted by conventional anatomic imaging alone (5) . Indeed, aneurysms not infrequently rupture below the current threshold (55 mm in diameter) for elective repair, and many patients with aneurysms >70 mm never experience rupture (6) . There is therefore a need to develop more reliable methods to identify patients who are at particular risk for AAA expansion and rupture (7) .
In AAA disease, degradation of the extracellular matrix occurs in response to the accumulation of inflammatory cells, such as macrophages and lymphocytes, and the activation of matrix metalloproteinases. The resulting milieu of cellular inflammation, tissue destruction, and necrosis can lead to cycles of further inflammation (8) . Focal "hotspots" of such intense biological activity have been identified in active aneurysm disease and can occur at the site of rupture (9) . We have recently demonstrated that the positron-emitting radiotracer 18 F-sodium fluoride ( 18 F-NaF) can identify areas of early microcalcification (10) that occur in response to necrotic inflammation in ruptured or high-risk human carotid (11) and coronary (12) atherosclerotic plaques. This tracer has not been assessed in patients with AAA, although loss of tissue integrity and necrotic inflammation may be central to its pathophysiology, underlie aneurysm expansion, and ultimately predict disease progression and outcome (7) . We hypothesized that 18 F-NaF uptake on positron emission tomography (PET) would highlight areas of microcalcification and AAA disease activity, representing regions prone to expansion and rupture. The main aims of this study were to determine whether 18 F-NaF uptake on combined PET and computed tomography (CT) is increased in AAA and whether this is associated with aneurysm growth (the primary endpoint) and subsequent rates of AAA repair or rupture. Ultrasound scans were carried out in an accredited clinical vascular science laboratory using a standardized protocol with known interobserver variability of 3.4% (14) . The AAA growth rate was determined using the AAA maximum anteroposterior diameter obtained To estimate 18 F-NaF uptake, the maximum standardized uptake values (SUVs) (a validated measure of tissue radiotracer uptake) were quantified from regions of interest (Online Appendix) (15) .
METHODS
Maximum tissue-to-background ratios (TBRs) were then calculated, after correction for blood pool activity using the averaged mean SUVs of 3 consecutive regions of interest from the right atrium, according to our previously described technique (16) . Although TBR max was used for our primary analysis (12) , we also investigated other methods for quantification, including SUV max and corrected SUV max (calculated by subtracting the blood pool activity from SUV max ) (17) . Finally, we adopted the "most diseased segment" (MDS) approach, as suggested by others (11, 16, (18) (19) (20) . The MDS TBR max was calculated as the average TBR max across 3 axial slices centered on the region of the aneurysm with the highest tracer activity (11) . 
RESULTS
A total of 145 patients with AAA were screened for inclusion: 136 were approached, and 76 patients ultimately attended for the scanning visit. Four patients underwent protocol development scans, had incomplete data, and were excluded from the final analysis, leaving a total of 72 patients with AAA and 20 control subjects ( Figure 2 ). Patients were predominantly elderly (mean age 72.5 AE 6.9 years) men (84.7%) with multiple cardiovascular risk factors, including hypertension (65.3%) and hypercholesterolemia (81.9%) ( Table 1) . More than 90% were current or ex-smokers (27.8% and 65.3%, respectively), with a mean baseline AAA diameter of 48.8 AE 7.7 mm. Control subjects were younger (mean age 65.2 AE 2.8 years) but also predominantly men (95.0%), and 40% were current (25%) or prior (15%) smokers.
CASE-CONTROL STUDY. Twenty patients with AAA were matched for age, sex, and smoking status with the 20 control subjects ( Table 1) . Background blood pool activity in the right atrium was similar between groups (log 2 SUV mean À0.570 AE 0.517 vs. À0.588 AE 0.531; difference 0.018; 95% confidence interval [CI]: À0.340 to 0.376; p ¼ 0.919). Fluorine-18-NaF uptake was higher in the AAA when compared with the abdominal aorta of control subjects irrespective of the method of quantification (e.g., log 2 MDS TBR max 1.712 AE 0.560 vs. 1.314 AE 0.489; difference 0.398; 95% CI: 0.057 to 0.739; p ¼ 0.023) (Online Table 1 ).
In contrast to control aortic tissue, AAA tissue demonstrated ex vivo 18 Table 1 ) than control subjects. However, no differences in 18 F-NaF uptake were observed between these groups in either the descending thoracic aorta or the nonaneurysmal abdominal aorta. Although there appeared to be some differences with respect to diastolic blood pressure, body mass index, and peripheral arterial disease, the trend was inconsistent across the tertiles ( Table 1) . 18 F-NaF UPTAKE AND ANEURYSM GROWTH. During 510 AE 196 days of follow-up, the median AAA The 20 patients for the case-control study were selected from within the cohort study population. AAA ¼ abdominal aortic aneurysm; CT ¼ computed tomography;
PET ¼ positron emission tomography. Patients with aneurysms in the highest tertile of 18 F-NaF uptake were more likely to experience AAA repair or rupture during follow-up (15.3% vs. 5.6%; log-rank p ¼ 0.043) ( Table 2) . They also had a reduced time to AAA event: 572 days versus 735 days for AAA repair (log-rank p ¼ 0.014) and 572 days versus 709 days for the composite of AAA repair or rupture (log-rank p ¼ 0.043) ( Figure 4) . In those patients who experienced AAA events, 18 Forsythe et al. B1) and calcification (black, Von Kossa stain, magnification Â200; B2) in the aortic aneurysm tissue that is not apparent in control aorta (A1, A2). Table 2 ).
DISCUSSION
In this prospective series of clinical studies, we have demonstrated for the first time that 18 F-NaF uptake is specifically increased in AAA and relates to areas of advanced aneurysmal disease. Moreover, 18 F-NaF uptake is a major predictor of aneurysm expansion and clinical outcome that is additive to standard clinical risk factors, including aneurysm diameter.
This is the first study to demonstrate that an imaging biomarker of disease activity can add to the risk prediction of AAA and to suggest that this approach might refine clinical decisions regarding the need for surgery and improve patient outcomes (Central Illustration).
Our studies have several major strengths and prominent observations. First, we have shown AAA tissue demonstrates markedly increased levels of 18 F-NaF uptake that far exceed those seen in control volunteers. Perhaps more important, uptake of the AAA also exceeds that observed in the nonaneurysmal aorta within the same patient. Second, we demonstrate that 18 F-NaF uptake localized to areas of AAA disease, highlighting diseased areas of poor tissue integrity that may be susceptible to aneurysm expansion and clinical events. Third, we assessed the potential clinical value of this technique in a cohort of patients with extended follow-up in which the clinicians responsible for the patient's care were unaware of the findings of PET-CT. It is therefore salient to note that 18 F-NaF uptake predicted expansion and clinical outcomes in addition to clinical risk factors including AAA diameter, especially as the latter drives the decision for elective AAA repair.
Fourth, this is the largest dedicated study using PET-CT in AAA disease to date and the first clinical study to investigate 18 F-NaF PET-CT in AAA disease progression (21) . Finally, this was a prospective clinical cohort study, in contrast with many previous studies of PET-CT in patients with AAA that are based on retrospective data, often obtained from cohorts derived from oncological imaging practice.
We previously demonstrated that 18 F-NaF selectively binds to microcalcification in coronary (11) and carotid atherosclerotic (10, 11) plaques and that this is associated with plaque vulnerability and rupture. We (11, 12) and others (22) have also shown that 18 F-NaF binds to areas of tissue necrosis-associated myocardial and cerebral infarction. In our present study, data from histology and micro-PET-CT indicate that this tracer behaves in a similar fashion in AAA. Increased 18 F-NaF uptake was most marked in AAA tissue with advanced disease and active calcification. We suggest that 18 F-NaF uptake again relates to microcalcification and is particular to the most diseased areas associated with tissue disruption and loss of integrity. Interestingly, we also showed that 18 F-NaF was distinct from AAA macrocalcification detected by CT and that the latter is not associated with expansion or AAA events, suggesting that once established, dense calcified deposits represent a more stabilized biological state.
Most previous clinical studies using PET-CT in AAA disease have focused on the use of 18 Fluorine-18-sodium fluoride uptake is specific to abdominal aortic aneurysm tissue, is proportional to the rate of aneurysm expansion, and predicts the risk for repair or rupture independent of aneurysm diameter. 
